Paderborn, October 10, 2024 - Four 20 Pharma GmbH, one of the leading suppliers of medicinal cannabis in Germany, announces the launch of a new range of medicinal cannabis flowers. The "Huala" brand product lines are aimed at patients and pharmacies who are looking for high-quality flowers at moderate prices. With this expansion of the brand range, Four 20 Pharma is responding to the growing demand for affordable medicinal cannabis options on the German market.
Berlin, October 8, 2024 – Four 20 Pharma GmbH (Four 20 Pharma), one of the leading medical cannabis companies in Germany, looks back on a successful first participation in the autumn congress of the German Society for Pain Medicine (DGS), which took place in Berlin from October 3 to 5, 2024. As a sponsor and exhibitor, the company presented its expertise in the field of medical cannabis and was represented with a stand in the industrial exhibition. There, representatives of the company answered questions from numerous interested participants
Essen/Paderborn, September 23, 2024 — The organizers, the anesthesiology department of the Korbach City Hospital and Four 20 Pharma GmbH (Four 20 Pharma), had expected 50 participants - over 200 doctors, medical assistants and psychotherapists actually came to learn about cannabis in medicine and to learn everything about the promising new therapy option. After the welcome by Matthias Hentrich, chief physician of anesthesiology, operative intensive care medicine and emergency medicine at the Korbach City Hospital, Dr. med. Dipl.-Chem. Konrad F. Cimander, an expert in the fields of addiction medicine, infectiology and cannabis medicine, led the program. Among other things, he gave an insight into the mode of action of the various components, presented case studies and explained the current legal framework.